Sen-Jam Pharmaceutical Announces Upcoming Completion of SJP-002C Clinical Trial, Offering Hope for a Safe, Potent, and Globally Affordable Treatment for Upper Respiratory Infections and COVID-19
/PRNewswire/ -- Sen-Jam Pharmaceutical, a leading innovator in the development of therapeutics for age-related diseases, is pleased to announce the upcoming...